Clinical Trials | April 22, 2026
Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
By cutting pain crises & boosting haemoglobin
By cutting pain crises & boosting haemoglobin
The company allocated €56 million to research and development for next-generation line solutions
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
The trial also demonstrated significant improvements across multiple secondary endpoints
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Subscribe To Our Newsletter & Stay Updated
